Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 162 member B (FAM162B) is a protein-coding gene that is predicted to be a membrane-associated protein, found in the plasma membrane[3][1]. It is an understudied protein with functions that are not yet fully characterized, though implicated in both developmental anomalies (such as neural crest cell regulation and Hirschsprung disease) and in cancer (with roles as a tumor suppressor candidate in lung and possible prognostic marker in prostate and oral squamous cell carcinomas). FAM162B has been highlighted in several genetic and prognostic studies but is not established as a canonical receptor, enzyme, or classical drug target[1][3]. The protein's mechanisms, interacting partners, and direct functional roles remain subjects for further research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 162 member B (FAM162B).